Status:
RECRUITING
Multimodal Study of the Human Brain Epilepsy Tissue
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
ICM Co. Ltd.
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Focal Drug-resistant Epilepsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The TIPI2 study is a blood and tissue collection protocol to create an annotated biorepository to support research in drug-resistant epilepsy. The aim of the study will be to identify new pathophysio...
Detailed Description
This study aims to investigate blood and brain samples from patients with drug-resistant epilepsy in order to identify new pathophysiological biomarkers. The investigators will first conduct multimod...
Eligibility Criteria
Inclusion
- 18 yo or above
- patients with a focal drug-resistant epilepsy
- patients hospitalized for a pre-surgical evaluation or for an epilepsy surgery
- consent obtained from the patient, or legally authorized representative
- affiliated to a social security system
Exclusion
- None
Key Trial Info
Start Date :
February 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2037
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06022055
Start Date
February 29 2024
End Date
February 28 2037
Last Update
July 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière Hospital
Paris, France, 75013